Alisha Badal

Alisha Badal is pursuing a PhD in molecular and cell biology at the University of the Witwatersrand. Her research aims to incorporate advanced molecular gene editing techniques to enhance the efficacy of targeted anti-cancer drugs to treat triple-negative breast cancer. A significant component of her research focuses on the development of a Silver(I) phosphine complex as a novel anti-cancer drug to activate apoptosis cell death in breast cancer with high efficacy and safety. She has a MSc in molecular and cell biology from the University of the Witwatersrand and a BSc in biochemistry and human physiology from the University of Johannesburg.